Skip to content
  • Job Openings
  • Contact Us
Freenome Holdings, Inc. logo
Main Menu
  • Our Science
  • Clinical Expertise
    • Our Studies
    • Our Publications
  • Our Company
    • About Our Company
    • Leadership
    • Partnerships
  • Newsroom
  • Careers
    • Our Work
    • Job Openings
Freenome Holdings, Inc. logo
Main Menu
  • Our Science
  • Clinical Expertise
    • Our Studies
    • Our Publications
  • Our Company
    • About Our Company
    • Leadership
    • Partnerships
  • Newsroom
  • Careers
    • Job Openings
  • Contact Us
  • View All Posters

Close

Presentations

Manuscripts

Presentations

Performance of a Blood-Based Test for Colorectal Cancer Screening Adjusted to the U.S. Census Age and Sex Distribution
2025 ASCO-GI
Test Performance and Lesion Characteristics in a Large Clinical Validation Study of a Blood-Based Screening Test for the Early Detection of Colorectal Cancer
2024 ACG
Projected Benefit and Cost-Effectiveness of Offering a Choice of Blood-Based Screening Versus Existing Screening Tests for Colorectal Cancer in Two Real-World Settings
2024 ACG
Enhancing Diversity and Inclusion in the PREEMPT CRC Study Through Strategic Site Selection and Innovative Recruitment Tools
2024 ACG
Clinical Evaluation of a New Blood-Based Test for Colorectal Cancer Screening 
2024 EDCC
Clinical Evaluation of a New Blood-Based Test for Colorectal Cancer Screening
2024 Western CRC Consortium Conference
Load More

Manuscripts

Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection

Nature Communications

3300 Marina Boulevard
Brisbane, CA
94005

Contact Us

Privacy Policy

Terms of Use

Cookie Notice

Twitter X logo

©2025 Freenome Holdings, Inc. The following are registered trademarks of Freenome Holdings, Inc.: FREENOME®, PREEMPT CRC® and AI-EMERGE®. All rights reserved.

  • Services
  • About
  • Reviews
  • Why Us
  • Contact
  • Home
  • Services
  • About
  • Reviews
  • Why Us
  • Contact
  • Home